Cargando…
Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598191/ https://www.ncbi.nlm.nih.gov/pubmed/34309676 http://dx.doi.org/10.1093/asj/sjab229 |
| _version_ | 1784600763817787392 |
|---|---|
| author | Kaufman-Janette, Joely Avelar, Rui L Biesman, Brian S Draelos, Zoe Diana Gross, John E Jones, Derek H Lupo, Mary P Maas, Corey S Schlessinger, Joel Shamban, Ava Teresa Sundaram, Hema Weinkle, Susan H Young, Vernon L |
| author_facet | Kaufman-Janette, Joely Avelar, Rui L Biesman, Brian S Draelos, Zoe Diana Gross, John E Jones, Derek H Lupo, Mary P Maas, Corey S Schlessinger, Joel Shamban, Ava Teresa Sundaram, Hema Weinkle, Susan H Young, Vernon L |
| author_sort | Kaufman-Janette, Joely |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8598191 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85981912021-11-18 Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients Kaufman-Janette, Joely Avelar, Rui L Biesman, Brian S Draelos, Zoe Diana Gross, John E Jones, Derek H Lupo, Mary P Maas, Corey S Schlessinger, Joel Shamban, Ava Teresa Sundaram, Hema Weinkle, Susan H Young, Vernon L Aesthet Surg J Corrigenda Oxford University Press 2021-07-26 /pmc/articles/PMC8598191/ /pubmed/34309676 http://dx.doi.org/10.1093/asj/sjab229 Text en © 2021 The Aesthetic Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigenda Kaufman-Janette, Joely Avelar, Rui L Biesman, Brian S Draelos, Zoe Diana Gross, John E Jones, Derek H Lupo, Mary P Maas, Corey S Schlessinger, Joel Shamban, Ava Teresa Sundaram, Hema Weinkle, Susan H Young, Vernon L Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title | Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_full | Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_fullStr | Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_full_unstemmed | Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_short | Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_sort | corrigendum to: the first of two one-year, multicenter, open-label, repeat-dose, phase ii safety studies of prabotulinumtoxina for the treatment of moderate to severe glabellar lines in adult patients |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598191/ https://www.ncbi.nlm.nih.gov/pubmed/34309676 http://dx.doi.org/10.1093/asj/sjab229 |
| work_keys_str_mv | AT kaufmanjanettejoely corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT avelarruil corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT biesmanbrians corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT draeloszoediana corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT grossjohne corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT jonesderekh corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT lupomaryp corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT maascoreys corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT schlessingerjoel corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT shambanavateresa corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT sundaramhema corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT weinklesusanh corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT youngvernonl corrigendumtothefirstoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients |